Home Cart Sign in  
Chemical Structure| 24512-62-7 Chemical Structure| 24512-62-7

Structure of Gardenoside
CAS No.: 24512-62-7

Chemical Structure| 24512-62-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gardenoside, a natural product isolated and purified from the fruits of Gardenia jasminoides Ellis, has anti-inflammatory, analgesic activities.

Synonyms: NSC 325664

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gardenoside

CAS No. :24512-62-7
Formula : C17H24O11
M.W : 404.37
SMILES Code : O=C(C1=CO[C@@H](O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)[C@@]3([H])[C@]1([H])C=C[C@@]3(O)CO)OC
Synonyms :
NSC 325664
MDL No. :MFCD00017727

Safety of Gardenoside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HL-60 5 μM 48 hours Evaluate the inhibitory effect of Gardenoside on AML cell proliferation Genes Dis. 2023 Jan 25;11(1):397-412
U-937 5 μM 48 hours Evaluate the inhibitory effect of Gardenoside on AML cell proliferation Genes Dis. 2023 Jan 25;11(1):397-412
THP-1 5 μM 48 hours Evaluate the inhibitory effect of Gardenoside on AML cell proliferation Genes Dis. 2023 Jan 25;11(1):397-412
HepG2 cells 10 µM, 20 µM 24 hours To study the effect of Gardenoside on FFAs-induced steatosis in HepG2 cells, results showed that Gardenoside significantly reduced intracellular lipid accumulation. Int J Mol Sci. 2015 Nov 20;16(11):27749-56
HepG2 cells 10 µM, 20 µM 24 hours To evaluate the effect of Gardenoside on HepG2 cell viability, results showed that 10 and 20 µM Gardenoside had no significant toxic effect on cell viability. Int J Mol Sci. 2015 Nov 20;16(11):27749-56
BRL-3A rat liver cells 100–500 µg/mL 24 hours Evaluate the effect of Gardenoside on cell viability. Results showed that Gardenoside inhibited cell growth in a dose-dependent manner at concentrations of 100–500 µg/mL. Molecules. 2019 Oct 30;24(21):3920

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
NOD/SCID mice AML patient-derived xenograft model Intraperitoneal injection 15 mg/kg Three times a week for three weeks Evaluate the anti-tumor effect of Gardenoside combined with rapamycin in AML mouse model Genes Dis. 2023 Jan 25;11(1):397-412
Kunming mice Montmorillonite-induced constipation model Intragastric administration 50 mg/kg Once daily for 9 days To study the relieving effect of Gardenoside on constipated mice. Results showed that Gardenoside increased the propelling rate of activated carbon in the small intestines of mice, accelerated the discharge of the first black stool, regulated the levels of gastrointestinal hormones in serum, and improved oxidative stress and tissue damage. RSC Adv. 2020 Mar 11;10(17):10368-10381
BABL/C mice S. aureus-induced mastitis model 10, 20, 40 mg/kg Sacrificed after 24 hours GAD alleviated inflammation and ferroptosis by activating the Nrf2/SLC7A11/GPX4 signaling pathway, improving mammary histopathological damage Microbiol Spectr. 2025 Jan 7;13(1):e0226224

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.47mL

0.49mL

0.25mL

12.36mL

2.47mL

1.24mL

24.73mL

4.95mL

2.47mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories